In contrast, the transcript levels of CHRNA2 and CHRNA10 were shown to be dramatically decreased in primary tumors compared to normal tissues derived from HNSCC patients (Figure 1B). This evidence concerns the gene CHRNA2 and head and neck squamous cell carcinoma.